You are here

AusPAR: ChAdOx1-S

Related information


How to access a pdf or Word document

*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.

Australian Public Assessment Report

16 February 2021
AusPAR Details
AusPAR
Active Ingredient
ChAdOx1-S
Product Name
COVID-19 Vaccine AstraZeneca
Sponsor
AstraZeneca Pty Ltd
Submission Number
PM 2020 06115 1-2
Submission Type
New biological entity
Decision
Approved for provisional registration
AusPAR Date
15 February 2021
Publication Date

16 February 2021